Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.
Front Immunol. 2022 Jul 14;13:880647. doi: 10.3389/fimmu.2022.880647. eCollection 2022.
While chemokines were originally described for their ability to induce cell migration, many studies show how these proteins also take part in many other cell functions, acting as adaptable messengers in the communication between a diversity of cell types. In the nervous system, chemokines participate both in physiological and pathological processes, and while their expression is often described on glial and immune cells, growing evidence describes the expression of chemokines and their receptors in neurons, highlighting their potential in auto- and paracrine signalling. In this study we analysed the role of nociception in the neuronal chemokinome, and in turn their role in axonal growth. We found that stimulating TRPV1 nociceptors induces a transient increase in CCL21. Interestingly we also found that CCL21 enhances neurite growth of large diameter proprioceptors . Consistent with this, we show that proprioceptors express the CCL21 receptor CCR7, and a CCR7 neutralizing antibody dose-dependently attenuates CCL21-induced neurite outgrowth. Mechanistically, we found that CCL21 binds locally to its receptor CCR7 at the growth cone, activating the downstream MEK-ERK pathway, that in turn activates N-WASP, triggering actin filament ramification in the growth cone, resulting in increased axonal growth.
趋化因子最初是因其诱导细胞迁移的能力而被描述的,但许多研究表明,这些蛋白质也参与了许多其他细胞功能,作为多种细胞类型之间通讯的适应性信使。在神经系统中,趋化因子参与生理和病理过程,虽然它们的表达通常在神经胶质细胞和免疫细胞上被描述,但越来越多的证据描述了趋化因子及其受体在神经元中的表达,突出了它们在自分泌和旁分泌信号中的潜在作用。在这项研究中,我们分析了伤害感受在神经元趋化因子组中的作用,以及它们在轴突生长中的作用。我们发现,刺激 TRPV1 伤害感受器会诱导 CCL21 的短暂增加。有趣的是,我们还发现 CCL21 增强了大直径本体感受器的神经突生长。与此一致,我们表明本体感受器表达 CCL21 受体 CCR7,并且 CCR7 中和抗体剂量依赖性地减弱 CCL21 诱导的神经突生长。在机制上,我们发现 CCL21 在生长锥处局部结合其受体 CCR7,激活下游 MEK-ERK 途径,该途径转而激活 N-WASP,触发生长锥中的肌动蛋白丝分支,导致轴突生长增加。